Coexistence of Cerebral Microbleeds and Amyloid Pathology in Patients with Cognitive Complaints

키워드

참고문헌 (39)

1. Perl DP, "Neuropathology of Alzheimer’s disease", Mt Sinai J Med, 77, pp.32~42 (2010)
2. Bennett DA, "Neuropathology of older persons without cognitive impairment from two community-based studies", Neurology, 66, pp.1837~1844 (2006)
3. Ferreira D, "The contribution of small vessel disease to subtypes of Alzheimer’s disease : a study on cerebrospinal fluid and imaging biomarkers", Neurobiol Aging, 70, pp.18~29 (2018)
4. Chételat G, "Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer’s disease", Neuroimage Clin, 2, pp.356~365 (2013)
5. Greenberg SM, "Cerebral microbleeds : a guide to detection and interpretation", Lancet Neurol, 8, pp.165~174 (2009)
6. Moran C, "Cerebral small vessel disease : a review of clinical, radiological, and histopathological phenotypes", Int J Stroke, 7, pp.36~46 (2012)
7. Attems J, "The overlap between vascular disease and Alzheimer’s disease--lessons from pathology", BMC Med, 12, pp.206~ (2014)
8. Arvanitakis Z, "Cerebral amyloid angiopathy pathology and cognitive domains in older persons", Ann Neurol, 69, pp.320~327 (2011)
9. Boyle PA, "Cerebral amyloid angiopathy and cognitive outcomes in communitybased older persons", Neurology, 85, pp.1930~1936 (2015)
10. Cordonnier C, "Brain microbleeds and Alzheimer’s disease : innocent observation or key player?", Brain, 134, pp.335~344 (2011)
11. Beach TG, "Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010", J Neuropathol Exp Neurol, 71, pp.266~273 (2012)
12. Petersen RC, "Mild cognitive impairment as a diagnostic entity", J Intern Med, 256, pp.183~194 (2004)
13. Dubois B, "Research criteria for the diagnosis of Alzheimer’s disease : revising the NINCDS-ADRDA criteria", Lancet Neurol, 6, pp.734~746 (2007)
14. Jessen F, "A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease", Alzheimers Dement, 10, pp.844~852 (2014)
15. Greenberg SM, "Diagnosis of cerebral amyloid angiopathy : evolution of the Boston criteria", Stroke, 49, pp.491~497 (2018)
16. Gregoire SM, "The Microbleed Anatomical Rating Scale(MARS) : reliability of a tool to map brain microbleeds", Neurology, 73, pp.1759~1766 (2009)
17. Kapeller P, "CT and MRI rating of white matter changes", J Neural Transm Suppl, 62, pp.41~45 (2002)
18. Wardlaw JM, "Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration", Lancet Neurol, 12, pp.822~838 (2013)
19. Viswanathan A, "Cerebral microhemorrhage", Stroke, 37, pp.550~555 (2006)
20. Haller S, "Cerebral microbleeds : imaging and clinical significance", Radiology, 287, pp.11~28 (2018)
21. Nakata-Kudo Y, "Microbleeds in Alzheimer disease are more related to cerebral amyloid angiopathy than cerebrovascular disease", Dement Geriatr Cogn Disord, 22, pp.8~14 (2006)
22. Akoudad S, "Association of cerebral microbleeds with cognitive decline and dementia", JAMA Neurol, 73, pp.934~943 (2016)
23. Uh J, "In vivo vascular hallmarks of diffuse leukoaraiosis", J Magn Reson Imaging, 32, pp.184~190 (2010)
24. Gordon BA, "The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia", Neuroimage Clin, 8, pp.246~252 (2015)
25. Marnane M, "Periventricular hyperintensities are associated with elevated cerebral amyloid", Neurology, 86, pp.535~543 (2016)
26. Lee S, "White matter hyperintensities are a core feature of Alzheimer’s disease : evidence from the dominantly inherited Alzheimer network", Ann Neurol, 79, pp.929~939 (2016)
27. Lee S, "White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer’s disease", PLoS One, 13, pp.e0195838~ (2018)
28. Yamada S, "Periventricular and deep white matter leukoaraiosis have a closer association with cerebral microbleeds than age", Eur J Neurol, 19, pp.98~104 (2012)
29. Roseborough A, "Associations between amyloid β and white matter hyperintensities : a systematic review", Alzheimers Dement, 13, pp.1154~1167 (2017)
30. Case NF, "Cerebral amyloid angiopathy is associated with executive dysfunction and mild cognitive impairment", Stroke, 47, pp.2010~2016 (2016)
31. Fotiadis P, "Cortical atrophy in patients with cerebral amyloid angiopathy : a case-control study", Lancet Neurol, 15, pp.811~819 (2016)
32. Greenberg SM, "Association of apolipoprotein E ε2 and vasculopathy in cerebral amyloid angiopathy", Neurology, 50, pp.961~965 (1998)
33. McCarron MO, "Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage", Ann N Y Acad Sci, 903, pp.176~179 (2000)
34. Nicoll JA, "High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy", Ann Neurol, 41, pp.716~721 (1997)
35. Esiri M, "Cerebral amyloid angiopathy, subcortical white matter disease and dementia: literature review and study in OPTIMA", Brain Pathol, 25, pp.51~62 (2015)
36. Pettersen JA, "Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study", Arch Neurol, 65, pp.790~795 (2008)
37. Attems J, "Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology", J Neurol Sci, 257, pp.49~55 (2007)
38. Shams S, "Cerebral microbleeds : different prevalence, topography, and risk factors depending on dementia diagnosis—the Karolinska Imaging Dementia Study", AJNR Am J Neuroradiol, 36, pp.661~666 (2015)
39. Shams S, "Cerebral microbleeds topography and cerebrospinal fluid biomarkers in cognitive impairment", J Cereb Blood Flow Metab, 37, pp.1006~1013 (2017)

관련 논문AI추천